Bcri Naïve News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The data showed notable responses, even among patients living with chronic lymphocytic leukemia (CLL) who had previous exposure to B-cell receptor–associated kinase inhibitors, the authors said.

Venetoclax venclextaPharmacyclics johnsonAbbvie genentechImage creditBrci pretreatedBcri naïveVenetoclax monotherapy